{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T22:35:07Z","timestamp":1784759707722,"version":"3.55.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["2021R1A5A8029490"],"award-info":[{"award-number":["2021R1A5A8029490"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.bbrc.2023.09.044","type":"journal-article","created":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T20:49:27Z","timestamp":1695156567000},"page":"249-270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["A review on Millepachine and its derivatives as potential multitarget anticancer agents"],"prefix":"10.1016","volume":"681","author":[{"given":"Shailima","family":"Rampogu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pallavi","family":"Badvel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung","family":"Hoon Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongseong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4291-9149","authenticated-orcid":false,"given":"Seon-Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keun Woo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2023.09.044_bib1","doi-asserted-by":"crossref","first-page":"7762","DOI":"10.1021\/acs.chemrev.7b00020","article-title":"Chalcone: a privileged structure in medicinal chemistry","volume":"117","author":"Zhuang","year":"2017","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bbrc.2023.09.044_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111306","article-title":"Anticancer activity of natural and synthetic chalcones","volume":"22","author":"Constantinescu","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2023.09.044_bib3","doi-asserted-by":"crossref","first-page":"894","DOI":"10.3390\/biom11060894","article-title":"Chalcone derivatives: role in anticancer therapy","volume":"11","author":"Ouyang","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.bbrc.2023.09.044_bib4","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7678486","article-title":"Synthesis, characterization, and anticancer activity of new benzofuran substituted chalcones","volume":"2016","author":"Co\u015fkun","year":"2016","journal-title":"J. Chem."},{"key":"10.1016\/j.bbrc.2023.09.044_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.712824","article-title":"Novel butein derivatives repress DDX3 expression by inhibiting PI3K\/AKT signaling pathway in MCF-7 and MDA-MB-231 cell lines","volume":"11","author":"Rampogu","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbrc.2023.09.044_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-01292-5","article-title":"New chalcone derivatives as potential antimicrobial and antioxidant agent","volume":"11","author":"Okolo","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2023.09.044_bib7","article-title":"Biological role of chalcones in medicinal chemistry","volume":"vol. 9","author":"Tekale","year":"2020"},{"key":"10.1016\/j.bbrc.2023.09.044_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e13324","article-title":"Explicit molecular dynamics simulation studies to discover novel natural compound analogues as <em>Mycobacterium tuberculosis<\/em> inhibitors","volume":"9","author":"Rampogu","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.bbrc.2023.09.044_bib9","first-page":"130","article-title":"Antibacterial activity of three newly-synthesized chalcones & synergism with antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus","volume":"140","author":"Bo\u017ei\u0107","year":"2014","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.bbrc.2023.09.044_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103133","article-title":"Chalcone derivatives and their antibacterial activities: current development","volume":"91","author":"Xu","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bbrc.2023.09.044_bib11","doi-asserted-by":"crossref","first-page":"18343","DOI":"10.1021\/acsomega.8b03174","article-title":"Pharmacophore modeling, synthesis, and antibacterial evaluation of chalcones and derivatives","volume":"3","author":"Zhang","year":"2018","journal-title":"ACS Omega"},{"key":"10.1016\/j.bbrc.2023.09.044_bib12","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/S0960-894X(98)00179-6","article-title":"Synthesis and anti-inflammatory activity of chalcone derivatives","volume":"8","author":"Herencia","year":"1998","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbrc.2023.09.044_bib13","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.2174\/1568026617666170914160446","article-title":"Chalcone derivatives: anti-inflammatory potential and molecular targets perspectives","volume":"17","author":"Mahapatra","year":"2017","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bbrc.2023.09.044_bib14","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/1061186X.2020.1853759","article-title":"A comprehensive review on the antiviral activities of chalcones","volume":"29","author":"Elkhalifa","year":"2021","journal-title":"J. Drug Target."},{"key":"10.1016\/j.bbrc.2023.09.044_bib15","doi-asserted-by":"crossref","first-page":"24483","DOI":"10.1039\/D0RA03684F","article-title":"New chalcone derivatives: synthesis, antiviral activity and mechanism of action","volume":"10","author":"Fu","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.bbrc.2023.09.044_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jscs.2022.101590","article-title":"Design, synthesis and antiviral activities of chalcone derivatives containing pyrimidine","volume":"27","author":"Zhan","year":"2023","journal-title":"J. Saudi Chem. Soc."},{"key":"10.1016\/j.bbrc.2023.09.044_bib17","doi-asserted-by":"crossref","first-page":"795","DOI":"10.4155\/fmc-2022-0013","article-title":"Novel trypanocidal thiophen-chalcone cruzain inhibitors: structure- and ligand-based studies","volume":"14","author":"de Oliveira","year":"2022","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.bbrc.2023.09.044_bib18","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1039\/c3md00025g","article-title":"Synthesis of coumarin\u2013chalcone hybrids and evaluation of their antioxidant and trypanocidal properties","volume":"4","author":"Vazquez-Rodriguez","year":"2013","journal-title":"Medchemcomm"},{"key":"10.1016\/j.bbrc.2023.09.044_bib19","doi-asserted-by":"crossref","first-page":"4819","DOI":"10.1021\/jm980410m","article-title":"Antileishmanial chalcones: statistical design, synthesis, and three-dimensional quantitative structure-activity relationship analysis","volume":"41","author":"Nielsen","year":"1998","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbrc.2023.09.044_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2020.624678","article-title":"Identification of chalcone derivatives as inhibitors of leishmania infantum arginase and promising antileishmanial agents","volume":"8","author":"Garcia","year":"2021","journal-title":"Front. Chem."},{"key":"10.1016\/j.bbrc.2023.09.044_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.592654","article-title":"Pharmacological properties of chalcones: a review of preclinical including molecular mechanisms and clinical evidence","volume":"11","author":"Salehi","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbrc.2023.09.044_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/biom11081203","article-title":"Chalcones: synthetic chemistry follows where nature leads","volume":"11","author":"Jasim","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.bbrc.2023.09.044_bib23","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s10311-019-00959-w","article-title":"Chalcone synthesis, properties and medicinal applications: a review","volume":"18","author":"Rammohan","year":"2020","journal-title":"Environ. Chem. Lett."},{"key":"10.1016\/j.bbrc.2023.09.044_bib24","doi-asserted-by":"crossref","first-page":"27769","DOI":"10.1021\/acsomega.2c01779","article-title":"Synthesis of chalcones derivatives and their biological activities: a review","volume":"7","author":"Elkanzi","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.bbrc.2023.09.044_bib25","first-page":"1","article-title":"Chalcones: a review on synthesis and pharmacological activities","volume":"11","author":"Goyal","year":"2021","journal-title":"J. Appl. Pharmaceut. Sci."},{"key":"10.1016\/j.bbrc.2023.09.044_bib26","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12935-020-1114-5","article-title":"A novel chalcone derivative has antitumor activity in melanoma by inducing DNA damage through the upregulation of ROS products","volume":"20","author":"Li","year":"2020","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bbrc.2023.09.044_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2019.e01376","article-title":"Chalcone derivatives: synthesis, in vitro and in vivo evaluation of their anti-anxiety, anti-depression and analgesic effects","volume":"5","author":"Higgs","year":"2019","journal-title":"Heliyon"},{"key":"10.1016\/j.bbrc.2023.09.044_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.01341","article-title":"Synthesis of chalcone derivatives: inducing apoptosis of HepG2 cells via regulating reactive oxygen species and mitochondrial pathway","volume":"10","author":"Zhu","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbrc.2023.09.044_bib29","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1093\/carcin\/bgt087","article-title":"Millepachine, a novel chalcone, induces G 2\/M arrest by inhibiting CDK1 activity and causing apoptosis via ROS-mitochondrial apoptotic pathway in human hepatocarcinoma cells in vitro and in vivo","volume":"34","author":"Wu","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbrc.2023.09.044_bib30","doi-asserted-by":"crossref","first-page":"220","DOI":"10.2174\/1570179412666150122230447","article-title":"Solvent-drop grinding method: efficient synthesis, DPPH radical scavenging and anti-diabetic activities of chalcones, bis-chalcones, azolines, and bis-azolines","volume":"12","author":"M Gomha","year":"2015","journal-title":"Curr. Org. Synth."},{"key":"10.1016\/j.bbrc.2023.09.044_bib31","doi-asserted-by":"crossref","DOI":"10.4172\/2150-3494.1000011","article-title":"An efficient and operationally simple synthesis of some new chalcones by using grinding technique","volume":"2","author":"Zangade","year":"2011","journal-title":"Chem. Sci. J."},{"key":"10.1016\/j.bbrc.2023.09.044_bib32","first-page":"124","article-title":"Recent updates on synthetic strategies of chalcone scaffold and their heterocyclic derivatives","volume":"6","author":"Amin","year":"2023","journal-title":"J. Adv. Biomed. Pharm. Sci."},{"key":"10.1016\/j.bbrc.2023.09.044_bib33","doi-asserted-by":"crossref","first-page":"9445","DOI":"10.1016\/j.tet.2010.09.089","article-title":"Synthesis of chalcones and flavanones using Julia\u2013Kocienski olefination","volume":"66","author":"Kumar","year":"2010","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bbrc.2023.09.044_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241310667","article-title":"Hydroxy chalcones and analogs with chemopreventive properties","volume":"24","author":"Birsa","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2023.09.044_bib35","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ultsonch.2010.09.010","article-title":"Synthesis of chalcone (3-(4-fluorophenyl)-1-(4-methoxyphenyl)prop-2-en-1-one): advantage of sonochemical method over conventional method","volume":"18","author":"Jarag","year":"2011","journal-title":"Ultrason. Sonochem."},{"key":"10.1016\/j.bbrc.2023.09.044_bib36","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.ultsonch.2012.11.018","article-title":"Facile sonochemical synthesis of novel pyrazolyne derivates at ambient conditions","volume":"20","author":"Pacheco","year":"2013","journal-title":"Ultrason. Sonochem."},{"key":"10.1016\/j.bbrc.2023.09.044_bib37","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1039\/D3SU00003F","article-title":"Solvent-free synthesis of chalcones using Mg(HSO4)2","volume":"1","author":"Saraci","year":"2023","journal-title":"RSC Sustain"},{"key":"10.1016\/j.bbrc.2023.09.044_bib38","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.bioorg.2019.01.019","article-title":"Innovative nano-carriers in anticancer drug delivery-a comprehensive review","volume":"85","author":"Dong","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bbrc.2023.09.044_bib39","first-page":"2169","article-title":"Xanthone conjugated amino acids as potential anticancer and DNA binding agents: molecular docking, cytotoxicity and sar studies, Anti-Cancer Agents","volume":"18","author":"Rakesh","year":"2018","journal-title":"Med. Chem."},{"key":"10.1016\/j.bbrc.2023.09.044_bib40","first-page":"845","article-title":"Synthesis of dihydrazones as potential anticancer and DNA binding candidates: a validation by molecular docking studies, anti-cancer agents","volume":"20","author":"Sridhara","year":"2020","journal-title":"Med. Chem."},{"key":"10.1016\/j.bbrc.2023.09.044_bib41","first-page":"488","article-title":"Recent development of sulfonyl or sulfonamide hybrids as potential anticancer agents: a key review, Anti-Cancer Agents","volume":"18","author":"Rakesh","year":"2018","journal-title":"Med. Chem."},{"key":"10.1016\/j.bbrc.2023.09.044_bib42","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.bioorg.2019.02.030","article-title":"The significance of N-methylpicolinamides in the development of anticancer therapeutics: synthesis and structure-activity relationship (SAR) studies","volume":"86","author":"Moku","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bbrc.2023.09.044_bib43","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.bmc.2017.11.026","article-title":"Podophyllotoxin derivatives as an excellent anticancer aspirant for future chemotherapy: a key current imminent needs","volume":"26","author":"Zhang","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bbrc.2023.09.044_bib44","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.bioorg.2018.06.009","article-title":"Multi-targetable chalcone analogs to treat deadly Alzheimer's disease: current view and upcoming advice","volume":"80","author":"Zhang","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bbrc.2023.09.044_bib45","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejmech.2019.03.063","article-title":"Synthetic approaches and pharmaceutical applications of chloro-containing molecules for drug discovery: a critical review","volume":"173","author":"Fang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bbrc.2023.09.044_bib46","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ejmech.2018.11.017","article-title":"Pharmaceutical and medicinal significance of sulfur (S(VI))-Containing motifs for drug discovery: a critical review","volume":"162","author":"Zhao","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bbrc.2023.09.044_bib47","doi-asserted-by":"crossref","first-page":"52281","DOI":"10.18632\/oncotarget.10739","article-title":"Millepachine, a potential topoisomerase II inhibitor induces apoptosis via activation of NF-\u03baB pathway in ovarian cancer","volume":"7","author":"Wu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrc.2023.09.044_bib48","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.fitote.2012.08.001","article-title":"Cytotoxic and apoptotic effects of constituents from Millettia pachycarpa Benth","volume":"83","author":"Ye","year":"2012","journal-title":"Fitoterapia"},{"key":"10.1016\/j.bbrc.2023.09.044_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.173975","article-title":"MIL-1, a novel antitumor agent derived from natural product millepachine, acts as tubulin polymerization inhibitor for the treatment of hepatocellular carcinoma","volume":"898","author":"Yan","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2023.09.044_bib50","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3390\/biom13020249","article-title":"Identification of inhibitors of tubulin polymerization using a CRISPR-edited cell line with endogenous fluorescent tagging of \u03b2-tubulin and histone H1","volume":"13","author":"Khachatryan","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.bbrc.2023.09.044_bib51","doi-asserted-by":"crossref","first-page":"9461","DOI":"10.1074\/jbc.RA117.001658","article-title":"The compound millepachine and its derivatives inhibit tubulin polymerization by irreversibly binding to the colchicine-binding site in \u03b2-tubulin","volume":"293","author":"Yang","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2023.09.044_bib52","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1002\/ptr.6180","article-title":"Millepachine showed novel antitumor effects in cisplatin-resistant human ovarian cancer through inhibiting drug efflux function of ATP-binding cassette transporters","volume":"32","author":"Wu","year":"2018","journal-title":"Phyther. Res."},{"key":"10.1016\/j.bbrc.2023.09.044_bib53","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1039\/C6OB02507B","article-title":"Synthesis, in vitro and in vivo evaluation of new hybrids of millepachine and phenstatin as potent tubulin polymerization inhibitors","volume":"15","author":"An","year":"2017","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bbrc.2023.09.044_bib54","doi-asserted-by":"crossref","first-page":"7977","DOI":"10.1021\/jm500849z","article-title":"Synthesis and biological evaluation of novel millepachine derivatives as a new class of tubulin polymerization inhibitors","volume":"57","author":"Yang","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbrc.2023.09.044_bib55","article-title":"Novel indole-containing hybrids derived from millepachine: synthesis, biological evaluation and antitumor mechanism study","volume":"28","author":"Liang","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.bbrc.2023.09.044_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2018.02.012","article-title":"Dual-targeting antitumor hybrids derived from Pt(IV) species and millepachine analogues","volume":"148","author":"Huang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bbrc.2023.09.044_bib57","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/j.bmc.2014.02.028","article-title":"Design, synthesis and biological evaluation of a series of pyrano chalcone derivatives containing indole moiety as novel anti-tubulin agents","volume":"22","author":"Wang","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bbrc.2023.09.044_bib58","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.ejmech.2013.01.007","article-title":"Synthesis and biological evaluation of novel pyranochalcone derivatives as a new class of microtubule stabilizing agents","volume":"62","author":"Cao","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bbrc.2023.09.044_bib59","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1254\/jphs.14077FP","article-title":"SKLB-M8 induces apoptosis through the AKT\/mTOR signaling pathway in melanoma models and inhibits angiogenesis with decrease of ERK1\/2 phosphorylation","volume":"126","author":"Wang","year":"2014","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.bbrc.2023.09.044_bib60","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1158\/2159-8290.CD-21-0212","article-title":"Independent drug action in combination therapy: implications for precision oncology","volume":"12","author":"Plana","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbrc.2023.09.044_bib61","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.4155\/fmc.09.113","article-title":"Natural product scaffolds as leads to drugs","volume":"1","author":"Newman","year":"2009","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.bbrc.2023.09.044_bib62","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.biotechadv.2015.08.001","article-title":"Discovery and resupply of pharmacologically active plant-derived natural products: a review","volume":"33","author":"Atanasov","year":"2015","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.bbrc.2023.09.044_bib63","doi-asserted-by":"crossref","DOI":"10.4103\/2231-4040.104709","article-title":"Natural products derived from plants as a source of drugs","author":"Veeresham","year":"2012","journal-title":"\\\"J. Adv. Pharm. Technol. Research\\\"\\\" (JAPTR)\\\""},{"key":"10.1016\/j.bbrc.2023.09.044_bib64","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25225243","article-title":"Important flavonoids and their role as a therapeutic agent","volume":"25","author":"Ullah","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bbrc.2023.09.044_bib65","series-title":"Woodhead Publishing","first-page":"185","article-title":"Chapter 10 - health benefits of flavonoids","author":"Ballard","year":"2019"},{"key":"10.1016\/j.bbrc.2023.09.044_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111808","article-title":"A comprehensive review on chemotherapeutic potential of galangin","volume":"141","author":"Rampogu","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbrc.2023.09.044_bib67","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.15885","article-title":"Curcumin Chalcone Derivatives Database (CCDD): a Python framework for natural compound derivatives database","volume":"11","author":"Rampogu","year":"2023","journal-title":"PeerJ"},{"key":"10.1016\/j.bbrc.2023.09.044_bib68","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nrc1075","article-title":"Tumour-cell invasion and migration: diversity and escape mechanisms","volume":"3","author":"Friedl","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrc.2023.09.044_bib69","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1073\/pnas.94.7.2776","article-title":"The cell cycle and cancer","volume":"94","author":"Collins","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X2301080X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X2301080X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T12:35:08Z","timestamp":1757766908000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X2301080X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":69,"alternative-id":["S0006291X2301080X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2023.09.044","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A review on Millepachine and its derivatives as potential multitarget anticancer agents","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2023.09.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}